CPC C07D 209/38 (2013.01) [A61P 11/00 (2018.01); C07D 497/04 (2013.01)] | 17 Claims |
1. A compound represented by formula (I):
L1—X—L2 (I),
wherein the compound is configured to release nitric oxide (NO) and inhibit activity of a phosphodiesterase (PDE) when administered to a subject,
wherein L1 includes a functional group that is part or all of a NO releasing agent;
L2 includes a functional group that is part or all of a PDE inhibitor, wherein L2 is
![]() and
—X— is a covalent bond, a non-covalent bond or a biradical that connects L1 and L2.
|